Los Angeles, California, March 15, 2014 /PRNewswire/ -- Taro Pharmaceuticals Inc. today announced that it has received final approval from the U. S. Food and Drug Administration (FDA) to market Los Angeles-based Cozaar, a brand name for Losartan, a medication for the treatment of hypertension and cardiac arrhythmias.
Under the terms of the approval, Taro will receive a marketing authorization for Cozaar from the FDA and will be able to market it in the US market within three business days of its approval. This approval will allow Taro to market Cozaar in the United States and throughout the world with high-quality generic drugs available in pharmacies.
About Los Angeles-based Cozaar
Los Angeles, California-based Taro Pharmaceuticals Inc. (Nasdaq: Taro) is a global specialty pharmaceutical company developing, manufacturing, producing and distributing generic medications. Taro has a specialty business unit located in Los Angeles, California. Taro has offices and manufacturing sites in approximately 30 countries. The company currently has a presence in over 120 countries and is in the process of expanding its U. distribution channels.
The Company is a leading global healthcare and business leader in cardiovascular products and has a portfolio of over 100 products, including over 30,000 brand and generic products. The Company's global operations include manufacturing and manufacturing of over 100 generic products and over 30,000 brand-name and brand-year sales. The Company is a member of the International Pharmaceutical Association and is an American company headquartered in Los Angeles.
About Taro Pharmaceuticals
Taro Pharmaceuticals, a specialty pharmaceutical company, is developing, producing and distributing generic medications in a wide variety of different dosage forms. The Company is a global specialty pharmaceutical company with a focus on cardiovascular products. The Company's products are available in generic forms as well as branded and generic formulations. The Company has approximately 200 products in production. Taro's pharmaceutical products are marketed through different strengths of generic or brand-name drugs. Taro's branded and generic formulations of pharmaceutical products are available in bulk, while the Company's generic pharmaceutical products are sold in a variety of strengths and formulations.
For more information about the Company's products, please visit our website at www.taro.com.
SOURCE Taro Pharmaceuticals Inc.
SOURCE: Taro Pharmaceuticals Inc.
PAPER & CAPITAL OF: <CINCINNATI, MIPRN: 9269425; Updated: 8/29/14
CIN: 5981816
Copyright (C) 2014 PR Newswire. All rights reserved
Media Enquiries into this matter:Media Enquiries:Michael Lippie1800 8941 - Email: [email protected]Media EnquiriesTaro:Investor:InvestorInvestorInvestorInvestorInvestorInvestorSOURCE:(c) 2015-2020 PR Newswire - All rights reserved
Taro Pharmaceuticals, Inc. -Consumer News CorpPRN:9269425Please contact the Pharmaceutical Marketing Authorization Board (PhMAB) via the contact page at[email protected]or call 1-888-233-2345 as required for a status update.For further information or queries please contact:
Consumer News Corp -Contact:1800 986 397 - Email: info@p-b.By Dr. Eric Koeppe
In a major study of the global cardiovascular risks of new drugs, the most commonly used drugs have a major link to serious cardiovascular disease. In the past two decades, a new drug was found to have the highest risk of cardiovascular disease. It was the only new drug on the market today to have a significant risk of fatal or nonfatal heart failure.
In a review by the medical editor of the New England Journal of Medicine, Dr. Steven Nissen, MD, was quoted in the New England Journal of Medicine as saying, “This is a very good drug that is used to treat hypertension, coronary artery disease and even angina.”
He said in a statement that he had been writing for an editor for over a decade. “The American Heart Association has long supported the use of drugs to lower high blood pressure.”
The study found that the drugs that are most at-risk are losartan, a brand name drug that is the mainstay of treatment for angina. The American Heart Association recommended using losartan in patients with established heart disease. The researchers also noted that patients who had high blood pressure and high levels of left ventricular systolic dysfunction (LVEF) would also be at increased risk of coronary heart disease. The researchers also pointed out that the drug that they described did not work as well in patients who had a risk factor for LVEF, including the use of losartan.
Dr. Nissen was not a physician, nor a cardiologist, nor a practicing pharmacist. He is an endocrinologist, cardiologist, cardiologist and urologist with the University of Washington School of Medicine in Seattle. Nissen is a clinical assistant professor of medicine and associate professor of medicine and head of urology at the University of Washington School of Medicine.
Koeppe was writing about the research on losartan, the drugs used in the treatment of hypertension and angina.
Losartan, a brand name drug for the drug Cozaar, was first approved in the United States in 1982. In 1997, it was approved by the FDA as a drug for the treatment of angina and is a member of the class of drugs called angiotensin-converting enzyme (ACE) inhibitors. Cozaar is also used to treat high blood pressure and coronary heart disease.The new drug is not approved for the treatment of hypertension. Koeppe said it was only approved for the treatment of angina and heart failure by the Food and Drug Administration in 1995. The FDA’s approval of Cozaar as a drug for the treatment of hypertension in 1990 also made it the only drug in the class of angiotensin receptor blockers to treat angina.
The new drug is not approved for the treatment of coronary artery disease. It was the only new drug to be approved by the FDA, the only drug on the market that is approved to treat a condition called “coronary artery disease.”
Koeppe told the New England Journal of Medicine that in 1999, he began writing for the medical editor for the New England Journal of Medicine, and that the study was “the first that we have ever done that we have shown that losartan [was] safe for people with heart disease.”
He said he has written for the medical editor for the New England Journal of Medicine since 1997. “I’ve written for the medical editor for more than a decade. It’s been the most important article I’ve written to date for the drug that I’ve written for,” he said.
Koeppe told the New England Journal of Medicine that he had been writing for the medical editor for almost three years. He said he had written several articles for the medical editor about the drug’s safety, but the drug was not shown to be safe for patients. He said he had been in the medical editor’s office and in his office for about two years.
He said he was asked to write for the medical editor after a review of his experience with the drug’s safety. He said he had not written for the medical editor for nearly two years.
He said the drug had been approved for patients who have had serious cardiovascular disease, and that the risk of the drug’s use “was fairly high.”
Cozaar is known for its long-lasting effects, making it a go-to treatment for managing and maintaining a healthy lifestyle. With its trusted brand-name version, COREX, Cozaar tablets are trusted and effective for treating a range of conditions. Whether you are seeking to ensure your wellness is maintained or to help manage any side effects experienced with the brand-name version, COREX stands out due to its longer-lasting effects.
One of the benefits of being aware of cozaar's active ingredient, Losartan Potassium, is its ability to work for those struggling with angina or heart conditions. When taken regularly, Cozaar (losartan) is a well-tolerated and effective option for managing angina and reducing the risk of heart attacks and strokes in those with a history of cardiovascular disease. However, with Cozaar's long-lasting effects, you can be assured of experiencing relief.
Losartan Potassium, commonly known by the brand name COREX, is a medication primarily prescribed for individuals with a condition known as angina. Angina is defined by a persistent narrowing of the aortic muscles, often the culprits behind causes heart disease. Losartan is particularly effective in individuals with a history of these conditions, as it helps alleviate symptoms and helps prevent future occurrences. When taken at the recommended dose, losartan is typically half the dose of medication available, making it a safe and effective option for treating angina and reducing the risk of heart issues.
It's important to note that Cozaar (losartan) is only effective when combined with a healthy diet and regular exercise. It is also important to take it at the same time each day to maintain its effectiveness. When taking Cozaar, it is important to follow the prescribed dosage and duration of treatment to ensure safety and effectiveness.
Cozaar (losartan) is an oral medication commonly prescribed for the treatment of conditions such as angina, coronary artery disease, and high blood pressure. It is also sometimes used to treat high blood pressure. Cozaar is primarily used to treat potassium-sparing aza-niazides, a medication classified as a potassium-sparing diuretic. It works by removing potassium from the blood, which can lead to symptoms like rapid heart rate, frequent dizziness, and weakness. When Cozaar is taken at the recommended dose and duration, it is equivalent to that of a standard potassium-sparing aza-niazide.
Angina or heart problems are usually managed by increasing the amount of potassium within the aorta. This will result in a decrease in blood pressure. Coronary artery disease, or C$- flap, is the result of a condition known as polyangitis.
Cozaar (losartan) is typically taken as needed, with the dose and duration prescribed by your healthcare provider.
Cozaar is a brand of the drug called Losartan. It is used to lower the level of a certain potassium salt in the blood, a salt that is essential to maintaining blood flow throughout the body. It is also used in hypertension treatment, as it decreases the production of blood pressure. This drug is safe to use, but it can cause side effects that need to be carefully monitored by healthcare professionals and are generally not life-threatening.
The most common side effects of Cozaar include:
These side effects usually go away on their own within a few hours, but they can also occur at any time and are more likely if a patient is taking more than one medication.
Cozaar can interact with other medications that are prescribed for different conditions. For instance, it can cause an increased risk of heart problems, blood clots, and kidney problems.
In some cases, Cozaar can also interact with other medications that can lower potassium levels. These include:
When taking Cozaar, it's important to inform your healthcare provider about all the medications you're taking. This includes prescription drugs, over-the-counter medications, vitamins, and herbal supplements.
If you're taking certain medications, it's important to inform your healthcare provider about all the drugs you're taking. This includes prescription drugs, over-the-counter medications, and dietary supplements.
If you're taking certain medications, it's important to inform your healthcare provider about all the medications you're taking.
VIDEO
Stade de France Pharmacy